Abound Wealth Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.7K Sell
540
-77
-12% -$6.21K 0.01% 249
2026
Q1
$43.7K Buy
617
+47
+8% +$3.52K 0.01% 268
2025
Q4
$45K Sell
570
-65
-10% -$5.14K 0.01% 244
2025
Q3
$52.3K Buy
635
+146
+30% +$11.5K 0.01% 204
2025
Q2
$39.4K Buy
489
+424
+652% +$32.7K 0.01% 236
2025
Q1
$5.19K Sell
65
-42
-39% -$3.49K ﹤0.01% 525
2024
Q4
$8.73K Sell
107
-3
-3% -$250 ﹤0.01% 411
2024
Q3
$9.04K Sell
110
-9
-8% -$672 ﹤0.01% 434
2024
Q2
$8.33K Sell
119
-13
-10% -$928 ﹤0.01% 398
2024
Q1
$9.79K Buy
132
+7
+6% +$488 ﹤0.01% 380
2023
Q4
$8.3K Buy
125
+9
+8% +$563 ﹤0.01% 405
2023
Q3
$7.32K Sell
116
-19
-14% -$1.18K ﹤0.01% 390
2023
Q2
$7.65K Buy
135
+51
+61% +$2.83K ﹤0.01% 391
2023
Q1
$4.88K Buy
84
+25
+42% +$1.69K ﹤0.01% 413
2022
Q4
$4.28K Sell
59
-59
-50% -$4.23K ﹤0.01% 380
2022
Q3
$7.18K Buy
+118
New +$7.54K ﹤0.01% 319

Other funds holding MET

Abound Wealth Management's MET Position: Q2 2026 in Review

Abound Wealth Management reduced its MetLife (MET) stake by 12% in Q2 2026, selling an estimated $6.21K and leaving 540 shares worth $45.7K. The position accounts for 0.01% of the portfolio, ranked #249.

Abound Wealth Management first reported a position in MET in Q3 2022 and has held it in 16 quarters since. The position peaked at $52.3K in Q3 2025. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Abound Wealth Management held 540 shares of MetLife worth $45.7K as of Q2 2026.
  • Abound Wealth Management sold 77 MetLife shares in Q2 2026, an estimated $6.21K.
  • MetLife made up 0.01% of Abound Wealth Management's portfolio in Q2 2026, its #249 holding.
  • Abound Wealth Management first reported a position in MetLife in Q3 2022 and has held it in 16 quarters since.
  • Abound Wealth Management's MetLife position peaked at $52.3K in Q3 2025.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.